Table 1. Clinicopathological characteristics of breast cancer patients enrolled into a window-of-opportunity study with simvastatin.

Parameters		N (%)
Age	Median age 52.7; range 41 to 70
Race	Chinese	6 (40.0)
	Malay	7 (46.7)
	Indian	1 (6.7)
	Others	1 (6.7)
Histological tumor type	Invasive ductal carcinoma	11 (73.3)
	Invasive lobular carcinoma	2 (13.3)
	Others	2 (13.3)
Tumor grade	2	8 (53.3)
	3	7 (46.7)
Estrogen Receptor	Negative	3 (20.0)
	Positive	12 (80.0)
Progesterone Receptor	Negative	3 (20.0)
	Positive	12 (80.0)
Human Epidermal Growth Factor Receptor 2	Negative	13 (86.7)
	Positive	2 (13.3)